AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

OTCMKTS:GNBTGenerex Biotechnology News Headlines

$0.58
-0.01 (-1.16 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.57
Now: $0.58
$0.60
50-Day Range
$0.54
MA: $0.61
$0.76
52-Week Range
$0.14
Now: $0.58
$1.65
Volume304,394 shs
Average Volume502,155 shs
Market Capitalization$46.48 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.67

Headlines

Generex Biotechnology (OTCMKTS GNBT) News Headlines

Source:
DateHeadline
NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide VaccineNuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine
finance.yahoo.com - July 2 at 1:14 PM
NuGenerex Immuno-Oncology Announces Board of DirectorsNuGenerex Immuno-Oncology Announces Board of Directors
finance.yahoo.com - July 1 at 12:57 PM
NuGenerex Immuno-Oncology Announces Shareholder Conference Call July 10, 2020 at 4:15 PMNuGenerex Immuno-Oncology Announces Shareholder Conference Call July 10, 2020 at 4:15 PM
finance.yahoo.com - June 26 at 9:59 AM
Generex Bio files for equity offeringGenerex Bio files for equity offering
seekingalpha.com - June 15 at 2:18 PM
Generex Bio achieves key milestone in COVID-19 vaccine programGenerex Bio achieves key milestone in COVID-19 vaccine program
seekingalpha.com - May 22 at 1:19 PM
Generex Subsidiary NGIO Advances COVID-19 Vaccine Program with the Manufacturing of Patent-Pending Ii-Key-SARS-CoV-2 PeptidesGenerex Subsidiary NGIO Advances COVID-19 Vaccine Program with the Manufacturing of Patent-Pending Ii-Key-SARS-CoV-2 Peptides
finance.yahoo.com - May 22 at 1:19 PM
Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 PandemicGenerex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
www.marketwatch.com - May 4 at 9:25 AM
Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 PandemicGenerex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
finance.yahoo.com - May 4 at 9:25 AM
Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer TrialGenerex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
finance.yahoo.com - April 28 at 2:19 PM
Generex Biotechnology Publishes Response to Congressional Letter Calling for COVID-19 Challenge Studies and Alternative Solution to Accelerate Vaccine DevelopmentGenerex Biotechnology Publishes Response to Congressional Letter Calling for COVID-19 Challenge Studies and Alternative Solution to Accelerate Vaccine Development
finance.yahoo.com - April 27 at 1:15 PM
Generex Biotechnology Provides Update on the Development of an Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 PandemicGenerex Biotechnology Provides Update on the Development of an Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
finance.yahoo.com - April 14 at 1:19 PM
Generex Biotechnology CEO Offers an Open Letter to Shareholders and Provides an Update on Corporate Response to the COVID-19 PandemicGenerex Biotechnology CEO Offers an Open Letter to Shareholders and Provides an Update on Corporate Response to the COVID-19 Pandemic
finance.yahoo.com - April 6 at 4:25 PM
Generex Biotechnology Subsidiary Olaregen Therapeutics’ Wound Conforming Matrix, Excellagen®, Awarded Strategic Acquisition Centers (SAC) Biologic Blanket Purchase Agreement (BPA) ContractGenerex Biotechnology Subsidiary Olaregen Therapeutics’ Wound Conforming Matrix, Excellagen®, Awarded Strategic Acquisition Centers (SAC) Biologic Blanket Purchase Agreement (BPA) Contract
finance.yahoo.com - March 30 at 6:04 PM
Generex Biotechnology Corp.Generex Biotechnology Corp.
www.barrons.com - March 26 at 9:42 PM
GNBT - Goldman Small Cap Research Issues Research Report on Generex Biotechnology Corp. and Interview with its CEOGNBT - Goldman Small Cap Research Issues Research Report on Generex Biotechnology Corp. and Interview with its CEO
www.bloomberg.com - March 26 at 9:42 PM
Generex Biotechnology Provides Guidance on the Safety of Ii-Key Peptide Vaccines for the Development of Effective Solutions to the SARS-CoV-2 Coronavirus PandemicGenerex Biotechnology Provides Guidance on the Safety of Ii-Key Peptide Vaccines for the Development of Effective Solutions to the SARS-CoV-2 Coronavirus Pandemic
finance.yahoo.com - March 19 at 1:07 PM
Generex Subsidiary NuGenerex Immuno-Oncology (Formerly Antigen Express) Files Form 10 Registration Statement with the Securities and Exchange CommissionGenerex Subsidiary NuGenerex Immuno-Oncology (Formerly Antigen Express) Files Form 10 Registration Statement with the Securities and Exchange Commission
finance.yahoo.com - March 12 at 5:23 PM
Generex Ii-Key Technology for Development of COVID-19 Vaccine Featured in MediaGenerex Ii-Key Technology for Development of COVID-19 Vaccine Featured in Media
finance.yahoo.com - March 11 at 2:41 PM
Generex Biotechnology Subsidiary NuGenerex Immuno-Oncology Sponsors Susan G. Komen More Than Pink WalkGenerex Biotechnology Subsidiary NuGenerex Immuno-Oncology Sponsors Susan G. Komen More Than Pink Walk
finance.yahoo.com - March 10 at 1:58 PM
Generex Signs Contract with EpiVax to Develop Ii-Key Peptide Vaccines to Address the Coronavirus PandemicGenerex Signs Contract with EpiVax to Develop Ii-Key Peptide Vaccines to Address the Coronavirus Pandemic
finance.yahoo.com - March 4 at 1:51 PM
Generex Biotechnology Appoints Independent Director S. Gail Eckhardt, MD to the NuGenerex Immuno-Oncology Board of DirectorsGenerex Biotechnology Appoints Independent Director S. Gail Eckhardt, MD to the NuGenerex Immuno-Oncology Board of Directors
finance.yahoo.com - March 2 at 1:52 PM
Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine TechnologyGenerex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology
finance.yahoo.com - March 2 at 1:52 PM
Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide VaccinesGenerex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines
finance.yahoo.com - February 27 at 2:39 PM
Generex Issues Clarification on Stock DividendsGenerex Issues Clarification on Stock Dividends
finance.yahoo.com - February 26 at 8:26 AM
Generex Congratulates their Shareholders as FINRA has Officially Posted the Approval of the Generex Corporate Action and Payment of the Generex and NuGenerex Immuno-Oncology Stock Dividends on Monday, February 24, 2020Generex Congratulates their Shareholders as FINRA has Officially Posted the Approval of the Generex Corporate Action and Payment of the Generex and NuGenerex Immuno-Oncology Stock Dividends on Monday, February 24, 2020
finance.yahoo.com - February 24 at 2:20 PM
Generex Biotechnology Announces Investor Conference Dial-In Details Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines and Corporate Update Thursday February 13, 2020 at 11:00 AM ESTGenerex Biotechnology Announces Investor Conference Dial-In Details Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines and Corporate Update Thursday February 13, 2020 at 11:00 AM EST
finance.yahoo.com - February 12 at 3:09 PM
Generex Biotechnology Announces Corporate Update and Investor Conference Call: Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines - Thursday February 13, 2020 at 11:00 AM ESTGenerex Biotechnology Announces Corporate Update and Investor Conference Call: Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines - Thursday February 13, 2020 at 11:00 AM EST
finance.yahoo.com - February 10 at 12:59 PM
Generex Declares NEW Dividend RECORD DATE: Monday, February 17, 2020Generex Declares NEW Dividend RECORD DATE: Monday, February 17, 2020
finance.yahoo.com - February 7 at 12:53 PM
Generex Biotechnology Discusses Coronavirus Solutions with The Stock Day PodcastGenerex Biotechnology Discusses Coronavirus Solutions with The Stock Day Podcast
finance.yahoo.com - February 6 at 2:23 PM
Generex Provides Stock Dividend Updates and GuidanceGenerex Provides Stock Dividend Updates and Guidance
finance.yahoo.com - February 6 at 2:23 PM
Generex Biotechnology Subsidiaries NuGenerex Immuno-Oncology and NuGenerex Diagnostics Working to Address the Coronavirus Pandemic and Emerging Risk of Avian Flu Using Ii-Key Peptide VaccinesGenerex Biotechnology Subsidiaries NuGenerex Immuno-Oncology and NuGenerex Diagnostics Working to Address the Coronavirus Pandemic and Emerging Risk of Avian Flu Using Ii-Key Peptide Vaccines
finance.yahoo.com - February 6 at 9:23 AM
Generex Biotechnology Appoints Independent Director Carol Nacy, PhD to the NuGenerex Immuno-Oncology Board of DirectorsGenerex Biotechnology Appoints Independent Director Carol Nacy, PhD to the NuGenerex Immuno-Oncology Board of Directors
finance.yahoo.com - February 5 at 1:13 PM
Generex Biotechnology Subsidiary Olaregen Therapeutix Receives VAC Approval and Ships Excellagen® to the Arizona Indian Health ServiceGenerex Biotechnology Subsidiary Olaregen Therapeutix Receives VAC Approval and Ships Excellagen® to the Arizona Indian Health Service
finance.yahoo.com - February 4 at 2:38 PM
Generex Biotechnology Appoints Independent Directors Craig Eagle, MD and Thomas Leonard to the NuGenerex Immuno-Oncology Board of DirectorsGenerex Biotechnology Appoints Independent Directors Craig Eagle, MD and Thomas Leonard to the NuGenerex Immuno-Oncology Board of Directors
finance.yahoo.com - January 30 at 1:34 PM
Generex Biotechnology Announces Interview with Richard Purcell, Executive Vice President of R&DGenerex Biotechnology Announces Interview with Richard Purcell, Executive Vice President of R&D
finance.yahoo.com - January 24 at 5:34 PM
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Introduction of Excellagen Aesthetics™Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Introduction of Excellagen Aesthetics™
finance.yahoo.com - January 17 at 12:57 PM
Generex Biotechnology Provides 2019 Year-End Summary & 2020 PlansGenerex Biotechnology Provides 2019 Year-End Summary & 2020 Plans
finance.yahoo.com - January 16 at 1:59 PM
Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday January 21, 2020 at 9:30 AMGenerex Biotechnology Announces Investor Conference Call Scheduled for Tuesday January 21, 2020 at 9:30 AM
finance.yahoo.com - January 15 at 5:54 PM
Generex Biotechnology to be Featured at 2020 Wall Street ConferenceGenerex Biotechnology to be Featured at 2020 Wall Street Conference
www.benzinga.com - January 8 at 10:52 AM
Generex Biotechnology Announces Update to Shareholder Stock DividendGenerex Biotechnology Announces Update to Shareholder Stock Dividend
finance.yahoo.com - January 3 at 5:14 PM
BRIEF-Generex Biotechnology Issues StatementBRIEF-Generex Biotechnology Issues Statement
www.msn.com - December 18 at 11:30 PM
Generex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of DirectorsGenerex Biotechnology Appoints Independent Director Marvin S. Hausman, MD to the NuGenerex Immuno-Oncology Board of Directors
finance.yahoo.com - December 11 at 11:01 AM
Generex Biotechnology Announces New Structure, Pay Date and Ex-Date for the Previously Postponed Shareholder Stock Dividend and Declares a New Share Dividend in NuGenerex Immuno-OncologyGenerex Biotechnology Announces New Structure, Pay Date and Ex-Date for the Previously Postponed Shareholder Stock Dividend and Declares a New Share Dividend in NuGenerex Immuno-Oncology
finance.yahoo.com - December 10 at 12:27 PM
Generex Biotechnology Provides Update on Pending DividendGenerex Biotechnology Provides Update on Pending Dividend
finance.yahoo.com - December 9 at 2:24 PM
Generex Biotechnology Announces Funding UpdateGenerex Biotechnology Announces Funding Update
finance.yahoo.com - December 5 at 2:14 PM
Generex Biotechnology Announces Postponement of Pending 1:1 DividendGenerex Biotechnology Announces Postponement of Pending 1:1 Dividend
finance.yahoo.com - November 27 at 5:37 PM
Reminder: Generex Investor Conference Call Friday, November 29, 2019Reminder: Generex Investor Conference Call Friday, November 29, 2019
www.benzinga.com - November 27 at 11:36 AM
Generex Biotechnology Issues Shareholder AlertGenerex Biotechnology Issues Shareholder Alert
finance.yahoo.com - November 26 at 4:49 PM
Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc.Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc.
finance.yahoo.com - November 25 at 3:52 PM
Generex Biotechnology Announces Investor...Generex Biotechnology Announces Investor...
www.benzinga.com - November 13 at 6:37 PM
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.